genrx palonosetron palonosetron (as hydrochloride) 250 microgram/5 ml solution for injection vial
apotex pty ltd - palonosetron hydrochloride, quantity: 56 microgram/ml - injection, solution - excipient ingredients: citric acid monohydrate; sodium citrate dihydrate; water for injections; mannitol - palonosetron is indicated for prevention of nausea and vomiting induced by cytotoxic chemotherapy.
palset palonosetron (as hydrochloride) 250 microgram/5 ml solution for injection vial
dr reddys laboratories australia pty ltd - palonosetron hydrochloride, quantity: 280 microgram (equivalent: palonosetron, qty 250 microgram) - injection, solution - excipient ingredients: water for injections; sodium acetate trihydrate; mannitol; hydrochloric acid; sodium hydroxide - palonosetron injection is indicated for prevention of nausea and vomiting induced by cytotoxic chemotherapy.
palonoset palonosetron (as hydrochloride) 250 microgram/5 ml solution for injection vial
dr reddys laboratories australia pty ltd - palonosetron hydrochloride, quantity: 280 microgram (equivalent: palonosetron, qty 250 microgram) - injection, solution - excipient ingredients: mannitol; sodium acetate trihydrate; water for injections; hydrochloric acid; sodium hydroxide - palonosetron injection is indicated for prevention of nausea and vomiting induced by cytotoxic chemotherapy.
palonosetron 250 micrograms solution for injection
fresenius kabi deutschland gmbh - palonosetron hydrochloride - solution for injection - 250 microgram(s) - serotonin (5ht3) antagonists; palonosetron
palzen injection solution for injection
palonosetron hydrochloride - solution for injection - palonosetron hydrochloride 0.25mg / 5ml - palonosetron
palonosetron fresenius kabi 250 µg inj. sol. i.v. vial
fresenius kabi sa-nv - palonosetron hydrochloride 0,056 mg/ml - eq. palonosetron 0,05 mg/ml - solution for injection - 250 µg - palonosetron hydrochloride 0.056 mg/ml - palonosetron
palonosetron fresenius kabi 250 µg inj. sol. i.v. pre-filled syr.
fresenius kabi sa-nv - palonosetron hydrochloride 0,056 mg/ml - eq. palonosetron 0,05 mg/ml - solution for injection in pre-filled syringe - 250 µg - palonosetron hydrochloride 0.056 mg/ml - palonosetron
palonosetron sandoz 250 µg inj. sol. i.v. vial
sandoz sa-nv - palonosetron hydrochloride 0,056 mg/ml - eq. palonosetron 0,05 mg/ml - solution for injection - 250 µg - palonosetron hydrochloride 0.281 mg - palonosetron
palonosetron juta 250 µg inj. sol. i.v. vial
juta pharma gmbh - palonosetron hydrochloride 0,056 mg/ml - eq. palonosetron 0,05 mg/ml - solution for injection - 250 µg - palonosetron hydrochloride 0.056 mg/ml - palonosetron
palonosetron seacross
a.l. medi-market ltd. - palonosetron as hydrochloride - solution for injection - palonosetron as hydrochloride 50 mcg / 1 ml - palonosetron - palonosetron seacross is indicated in adults and in paediatric patients 1 month of age and older for the prevention of acute nausea and vomiting associated with highly emetogenic cancer chemotherapy, and prevention of nausea and vomiting associated with moderately emetogenic cancer chemotherapy.